Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in pediatric eosinophilic esophagitis
NCT00358449Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of mepolizumab in eosinophilic esophagitis (EoE), sponsored by GSK. Started Sep 2006; status: completed.
02
Drugs
mepolizumab
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00358449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358449.